Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,397,759 papers from all fields of science
Search
Sign In
Create Free Account
reactive hyperplasia
Known as:
compensatory hyperplasia
, hyperplasia reactive
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
[Relationship of Expression of Circ_cgga162 with the Prognosis of Patients with Mantle Cell Lymphoma].
Yan Li
,
Zhen-Wei Jia
,
+5 authors
Jian-Min Luo
Zhongguo shi yan xue ye xue za zhi
2020
Corpus ID: 219899311
OBJECTIVE To investigate the expression of Circ_cgga162 in serum of mantle cell lymphoma (MCL) patients and analyze its potential…
Expand
Review
2018
Review
2018
The many ways to mend your liver: A critical appraisal
M. Alison
International journal of experimental pathology…
2018
Corpus ID: 46983109
In the latter half of the 20th century, our understanding of mammalian liver regeneration was shaped by the manner of…
Expand
2017
2017
[Relation of MiR-34a Expression in Diffuse Large B Cell Lymphoma with Clinical Prognosis].
Yiping Liu
,
Hong Hu
,
Fang Xu
,
J. Wen
Zhongguo shi yan xue ye xue za zhi
2017
Corpus ID: 43183111
OBJECTIVE To investigate the expression of miR-34a in serum of DLBCL patients, and to analyze its correlation with the expression…
Expand
2014
2014
Spectrum of pathologic lesions in superficial lymph node biopsies a one and half year study
Jaimin Panchal
,
Pushpalatha K. Pai
2014
Corpus ID: 71251518
Aim/Objective: The aim of this study is to analyse pathological spectrum of various neoplastic and non-neoplastic diseases…
Expand
2006
2006
[A study on the expression of myeloid cell leukemia 1 proteins and survivin and their relation with B cell apoptosis in non-Hodgkin's lymphoma].
X. Zuo
,
Xin Zhou
,
Juan Meng
,
Ke-jian Zhang
,
Xiao-hong Liu
,
Hua-qiang Yang
Zhonghua nei ke za zhi
2006
Corpus ID: 33491403
OBJECTIVE To explore the expression of myeloid cell leukemia 1 (MCL-1) proteins and survivin and its correlation with cell…
Expand
Review
2004
Review
2004
REVIEW OF STUDIES CONCERNING THE TUMORIGENICITY OF 2-BUTOXYETHANOL IN B6C3F1 MICE AND ITS RELEVANCE FOR HUMAN RISK ASSESSMENT
R. Boatman
,
R. Corley
,
T. Green
,
J. Klaunig
,
M. Udden
Journal of Toxicology and Environmental Health…
2004
Corpus ID: 24036428
The U.S. National Toxicology Program (NTP) has completed 2-yr inhalation exposures in rats and mice with 2-butoxyethanol (BE…
Expand
2002
2002
Fine‐needle aspiration biopsy and flow cytometry immunophenotyping of lymphoid and myeloproliferative disorders of the spleen
P. Zeppa
,
M. Picardi
,
+5 authors
L. Palombini
Cancer
2002
Corpus ID: 42129877
Flow cytometry (FC) is a useful adjunct to fine‐needle aspiration biopsy (FNAB) in the evaluation of lymphoproliferative…
Expand
2002
2002
[Pathologic/high-resolution CT correlation of focal lung lesions 5 mm or less in diameter: detection and identification by multidetector-row CT].
H. Ishikawa
Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta…
2002
Corpus ID: 25248953
PURPOSE To clarify the limitations of multidetector-row CT (MDCT) in detecting focal lung lesions of 5 mm or less in diameter by…
Expand
1995
1995
Quantitative study of AgNOR in differential diagnosis between non-Hodgkin's lymphoma and reactive hyperplasia.
X. Gan
Chinese Medical Journal
1995
Corpus ID: 23895078
The argyrophilic staining technique was used in differential diagnosis between non-Hodgkin's lymphoma (NHL) and reactive…
Expand
1988
1988
The effect of pancreatic and intestinal venous blood on hepatic atrophy and compensatory hyperplasia in the rat.
J. Rozga
,
B. Jeppsson
,
S. Bengmark
Acta physiologica Polonica
1988
Corpus ID: 30831610
Hepatotrophic effect of pancreatic and intestinal venous blood was studied in rats with mesocaval or distal splenocaval shunt…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE